References
- HavelPJControl of energy homeostasis and insulin action by adipocyte hormones: Leptin, acylation stimulating protein, and adiponectinCurr Opin Lipidol2002131515911790963
- ShimadaKMiyazakiTDaidaHAdiponectin and atherosclerotic diseaseClin Chim Acta20043441–211215149866
- KadowakiTYamauchiTAdiponectin and adiponectin receptorsEndocr Rev200526343945115897298
- HugCLodishHFThe role of the adipocyte hormone adiponectin in cardiovascular diseaseCurr Opin Pharmacol20055212913415780820
- FangXSweeneyGMechanisms regulating energy metabolism by adiponectin in obesity and diabetesBiochem Soc Trans200634Pt 579880117052201
- FruebisJTsaoTSJavorschiSProteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in miceProc Natl Acad Sci U S A20019842005201011172066
- BruceCRMertzVAHeigenhauserGJDyckDJThe stimulatory effect of globular adiponectin on insulin-stimulated glucose uptake and fatty acid oxidation is impaired in skeletal muscle from obese subjectsDiabetes200554113154316016249439
- PalanivelRFangXParkMGlobular and full-length forms of adiponectin mediate specific changes in glucose and fatty acid uptake and metabolism in cardiomyocytesCardiovasc Res200775114815717499232
- YamauchiTKamonJWakiHGlobular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosisJ Biol Chem200327842461246812431986
- ChenHMontagnaniMFunahashiTShimomuraIQuonMJAdiponectin stimulates production of nitric oxide in vascular endothelial cellsJ Biol Chem200327845450214502612944390
- LiCJSunHWZhuFLLocal adiponectin treatment reduces atherosclerotic plaque size in rabbitsJ Endocrinol2007193113714517400811
- OkamotoYAritaYNishidaMAn adipocyte-derived plasma protein, adiponectin, adheres to injured vascular wallsHorm Metab Res2000322475010741683
- OuchiNKiharaSAritaYAdipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophagesCirculation200110381057106311222466
- JunghansMKreuterJZimmerAAntisense delivery using protamine-oligonucleotide particlesNucleic Acids Res20002810E4510773093
- LochmannDWeyermannJGeorgensCPrasslRZimmerAAlbumin-protamine-oligonucleotide nanoparticles as a new antisense delivery system. Part 1: Physicochemical characterizationEur J Pharm Biopharm200559341942915760722
- WeyermannJLochmannDGeorgensCZimmerAAlbumin-protamine-oligonucleotide-nanoparticles as a new antisense delivery system. Part 2: Cellular uptake and effectEur J Pharm Biopharm200559343143815760723
- WernigKGriesbacherMAndreaeFDepot formulation of vasoactive intestinal peptide by protamine-based biodegradable nanoparticlesJ Control Release2008130219219818601963
- KratzerIWernigKPanzenboeckUApolipoprotein A-I coating of protamine-oligonucleotide nanoparticles increases particle uptake and transcytosis in an in vitro model of the blood-brain barrierJ Control Release2007117330131117239472
- KerkmannMLochmannDWeyermannJImmunostimulatory properties of CpG-oligonucleotides are enhanced by the use of protamine nanoparticlesOligonucleotides200616431332217155907
- Briley-SaeboKCMulderWJManiVMagnetic resonance imaging of vulnerable atherosclerotic plaques: Current imaging strategies and molecular imaging probesJ Magn Reson Imaging200726346047917729343
- ErdoganSLiposomal nanocarriers for tumor imagingJ Biomed Nanotechnol20095214115020055092
- CormodeDPSkajaaTFayadZAMulderWJNanotechnology in medical imaging: Probe design and applicationsArterioscler Thromb Vasc Biol2009297992100019057023
- ImmordinoMLDosioFCattelLStealth liposomes: Review of the basic science, rationale, and clinical applications, existing and potentialInt J Nanomedicine20061329731517717971
- SamadASultanaYAqilMLiposomal drug delivery systems: An update reviewCurr Drug Deliv20074429730517979650
- HardingJAEngbersCMNewmanMSGoldsteinNIZalipskySImmunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomesBiochim Biophys Acta1997132721811929271260
- WoodleMCControlling liposome blood clearance by surface-grafted polymersAdv Drug Deliv Rev1998321–213915210837640
- StarkBDebbagePAndreaeFMosgoellerWPrasslRAssociation of vasoactive intestinal peptide with polymer-grafted liposomes: Structural aspects for pulmonary deliveryBiochim Biophys Acta20071768370571417204237
- StarcherBA ninhydrin-based assay to quantitate the total protein content of tissue samplesAnal Biochem2001292112512911319826
- SinnHJSchrenkHHFriedrichEAViaDPDreselHARadioiodination of proteins and lipoproteins using N-bromosuccinimide as oxidizing agentAnal Biochem198817011861923389510
- PabstGGlobal properties of biomimetic membranes: Perspectives on molecular featuresBiophys Rev Lett2006115784
- WicklineSANeubauerAMWinterPMCaruthersSDLanzaGMMolecular imaging and therapy of atherosclerosis with targeted nanoparticlesJ Magn Reson Imaging200725466768017347992
- ChoudhuryRPFisherEAMolecular imaging in atherosclerosis, thrombosis, and vascular inflammationArterioscler Thromb Vasc Biol200929798399119213945
- SanzJFayadZAImaging of atherosclerotic cardiovascular diseaseNature2008451718195395718288186
- LindsayACChoudhuryRPForm to function: Current and future roles for atherosclerosis imaging in drug developmentNat Rev Drug Discov20087651752918483481
- NahrendorfMSosnovikDEWeisslederRMR-optical imaging of cardiovascular molecular targetsBasic Res Cardiol20081032879418324364
- LibbyPOkamotoYRochaVZFolcoEInflammation in atherosclerosis: Transition from theory to practiceCirc J201074221322020065609
- WoollardKJGeissmannFMonocytes in atherosclerosis: Subsets and functionsNat Rev Cardiol201072778620065951
- ManggeHAlmerGTruschnig-WildersMSchmidtAGasserRFuchsDInflammation, adiponectin, obesity and cardiovascular riskCurr Med Chem201017364511452021062254
- SessaGWeissmannGPhospholipid spherules (liposomes) as a model for biological membranesJ Lipid Res1968933103185646182
- MaruyamaKTakizawaTYudaTKennelSJHuangLIwatsuruMTargetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodiesBiochim Biophys Acta19951234174807880861
- UppalRCaravanPTargeted probes for cardiovascular MR ImagingFuture Med Chem 1;2345147020539821
- VoineaMSimionescuMDesigning of ‘intelligent’ liposomes for efficient delivery of drugsJ Cell Mol Med20026446547412611636
- OrtnerAWernigKKaislerRVPAC receptor mediated tumor cell targeting by protamine based nanoparticlesJ Drug Target201018645746720050817
- ParkerJCTransport and distribution of charged macromolecules in lungsAdv Microcirc198713150159
- ChonoSTauchiYMorimotoKInfluence of particle size on the distributions of liposomes to atherosclerotic lesions in miceDrug Dev Ind Pharm200632112513516455611
- MaiseyeuAMihaiGKampfrathTGadolinium-containing phosphatidylserine liposomes for molecular imaging of atherosclerosisJ Lipid Res200950112157216319017616
- AhsanFRivasIPKhanMATorres SuarezAITargeting to macrophages: Role of physicochemical properties of particulate carriers – liposomes and microspheres – on the phagocytosis by macrophagesJ Control Release2002791–3294011853916
- RoserMFischerDKisselTSurface-modified biodegradable albumin nano- and microspheres. II: Effect of surface charges on in vitro phagocytosis and biodistribution in ratsEur J Pharm Biopharm19984632552639885296
- NieuwdorpMMeuweseMCVinkHHoekstraJBKasteleinJJStroesESThe endothelial glycocalyx: A potential barrier between health and vascular diseaseCurr Opin Lipidol200516550751116148534
- PlumpASBreslowJLApolipoprotein E and the apolipoprotein E-deficient mouseAnnu Rev Nutr1995154955188527231
- SwirskiFKLibbyPAikawaELy-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromataJ Clin Invest2007117119520517200719